Arcellx Inc (ACLX)
88.04
+0.82
(+0.94%)
USD |
NASDAQ |
Nov 21, 14:23
Arcellx Price: 88.04 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 86.87 | 88.30 | 83.69 | 87.22 | 344946.0 |
| Nov 19, 2024 | 87.43 | 89.39 | 85.37 | 87.59 | 498221.0 |
| Nov 18, 2024 | 87.93 | 89.84 | 87.02 | 88.22 | 427514.0 |
| Nov 15, 2024 | 94.91 | 94.99 | 87.08 | 87.83 | 855372.0 |
| Nov 14, 2024 | 100.19 | 100.34 | 94.88 | 95.08 | 480348.0 |
| Nov 13, 2024 | 101.11 | 103.66 | 100.02 | 100.14 | 503227.0 |
| Nov 12, 2024 | 106.33 | 107.37 | 99.94 | 100.48 | 623201.0 |
| Nov 11, 2024 | 105.36 | 107.34 | 104.11 | 106.53 | 702326.0 |
| Nov 08, 2024 | 99.94 | 106.24 | 96.94 | 103.06 | 846034.0 |
| Nov 07, 2024 | 92.74 | 99.48 | 91.69 | 99.16 | 695786.0 |
| Nov 06, 2024 | 94.34 | 96.25 | 88.64 | 92.98 | 1.105M |
| Nov 05, 2024 | 80.22 | 87.74 | 77.00 | 87.12 | 2.331M |
| Nov 04, 2024 | 85.11 | 91.20 | 84.90 | 86.44 | 784410.0 |
| Nov 01, 2024 | 85.00 | 86.33 | 84.00 | 86.17 | 522636.0 |
| Oct 31, 2024 | 86.42 | 87.34 | 82.15 | 84.27 | 360513.0 |
| Oct 30, 2024 | 86.86 | 87.33 | 85.33 | 86.81 | 323130.0 |
| Oct 29, 2024 | 85.15 | 87.35 | 83.53 | 87.25 | 520100.0 |
| Oct 28, 2024 | 85.80 | 86.33 | 83.41 | 84.99 | 536564.0 |
| Oct 25, 2024 | 87.02 | 87.22 | 83.97 | 84.31 | 311170.0 |
| Oct 24, 2024 | 88.50 | 89.59 | 85.62 | 86.48 | 415021.0 |
| Oct 23, 2024 | 89.96 | 90.55 | 87.54 | 88.19 | 464613.0 |
| Oct 22, 2024 | 89.69 | 91.22 | 89.69 | 90.46 | 418764.0 |
| Oct 21, 2024 | 96.52 | 97.02 | 89.55 | 90.28 | 550587.0 |
| Oct 18, 2024 | 95.90 | 97.54 | 94.44 | 96.86 | 553022.0 |
| Oct 17, 2024 | 94.70 | 96.30 | 92.77 | 95.27 | 727893.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
7.21
Minimum
May 18 2022
106.53
Maximum
Nov 11 2024
40.20
Average
34.20
Median
Price Benchmarks
| Boston Scientific Corp | 91.35 |
| AbbVie Inc | 171.97 |
| NovaBay Pharmaceuticals Inc | 0.70 |
| Palatin Technologies Inc | 0.9146 |
| iBio Inc | 2.39 |
Price Related Metrics
| PS Ratio | 29.52 |
| Price to Book Value | 9.856 |
| Price to Free Cash Flow | 1283.93 |
| Earnings Yield | -0.81% |
| Market Cap | 4.761B |